New imaging method may spot brain tumor response faster than MRI
NCT ID NCT07469735
First seen Apr 01, 2026 · Last updated May 08, 2026 · Updated 5 times
Summary
This study looks at whether a special PET scan (18F-AGX) can detect early changes in brain tumors (low-grade IDH-mutant gliomas) during treatment with the drug Vorasidenib. Ten adults with recurrent or residual tumors will receive the drug and undergo both MRI and PET scans over 12 months. The goal is to see if PET can predict tumor growth or shrinkage sooner than standard MRI, which could help doctors adjust treatment earlier.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Huashan Hospital
Shanghai, Shanghai Municipality, 201100, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.